Literature DB >> 28837527

Prestained and Preloaded DMEK Grafts: An Evaluation of Tissue Quality and Stain Retention.

Dorian A Zeidenweber1, Khoa D Tran, Christopher S Sales, Stephen W Wehrer, Michael D Straiko, Mark A Terry.   

Abstract

PURPOSE: To examine endothelial cell damage and stain retention of prestained preloaded Descemet membrane endothelial keratoplasty (DMEK) grafts.
METHODS: DMEK grafts were stained with trypan blue or left unstained before loading into a Straiko modified Jones tube. A protocol to stain preloaded grafts inside the modified Jones tube and resulting cell loss was also examined. Endothelial cell loss was determined by vital dye staining after 3 days of cold storage and compared between the 3 groups. Eight additional grafts were stained, loaded, and shipped from Oregon to New York to assess stain stability. Stain retention and the ability to successfully inject and open these "prestained preloaded" grafts in cadaveric donor eyes were also evaluated.
RESULTS: Unstained preloaded DMEK grafts showed an overall cell loss of 15% ± 3% [95% confidence interval (CI), 11%-18%]. Prestained grafts had a cell loss of 16% ± 4% (95% CI, 10%-22%) and were not significantly different from unstained grafts (P = 1). Grafts stained while inside the modified Jones tubes had an average cell loss of 18% ± 2% (95% CI, 16%-20%, Pprestained = 0.15, Punstained = 0.09). All grafts shipped across the country and examined 3 days after preparation showed a decrease in stain intensity but were still deemed suitable for transplantation by an experienced DMEK surgeon.
CONCLUSIONS: It is possible to prestain and preload DMEK grafts without inducing additional endothelial cell loss. Consideration should be given to the interval between staining and surgery because stain can fade.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28837527     DOI: 10.1097/ICO.0000000000001329

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  5 in total

1.  Safety of Long-Term Storage and Shipping of Prestripped, Prestained, and Preloaded Descemet Membrane Endothelial Keratoplasty Tissue.

Authors:  Jason Hooton; Kyeong Hwan Kim; Stephen I Lentz; Nicholas Hicks; Kayla Jones; Kristen McCoy; Shahzad I Mian
Journal:  Cornea       Date:  2019-08       Impact factor: 2.651

2.  Viability of preloaded Descemet membrane endothelial keratoplasty grafts with 96-hour shipment.

Authors:  Conan Chen; Steven Jared Solar; John Lohmeier; Staci Terrin; Satya Baliga; Batya Gold Wiener; Daniel Schouten Lewis; Eric Chiang; Kali Alexandra Barnes; Akash Chaurasia; Allen O Eghrari
Journal:  BMJ Open Ophthalmol       Date:  2021-05-20

3.  Clinical Outcomes Of Descemet Membrane Endothelial Keratoplasty Using The Bonfadini-Todd Injector For Graft Insertion.

Authors:  Mehrnaz Ighani; Sezen Karakus; Allen O Eghrari
Journal:  Clin Ophthalmol       Date:  2019-09-20

4.  Overall clinical outcomes of Descemet membrane endothelial keratoplasty in 600 consecutive eyes: A large retrospective case series.

Authors:  Samar K Basak; Soham Basak; Nidhi Gajendragadkar; Mrinmoyee Ghatak
Journal:  Indian J Ophthalmol       Date:  2020-06       Impact factor: 1.848

5.  Comparing the effect of three Descemet membrane endothelial keratoplasty injectors on endothelial damage of grafts.

Authors:  Elizabeth Shen; Adam Fox; Brian Johnson; Marjan Farid
Journal:  Indian J Ophthalmol       Date:  2020-06       Impact factor: 1.848

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.